|
CONTENTS
|
|
|
|
Detection,
Prevention,
Screening
Diagnosis and evaluation
Etiology and pathogenesis
Integrative medicine
Overall management
Prognosis and outcome
Psychosocial aspects
Staging
|
|
|
|
DETECTION, PREVENTION, SCREENING
|
|
|
Le
JD, Tan N, Shkolyar E, Lu DY, Kwan L, Marks LS, Huang J, Margolis DJ,
Raman SS, Reiter RE.
Multifocality
and Prostate Cancer Detection by Multiparametric Magnetic Resonance
Imaging: Correlation with Whole-mount Histopathology.
Eur Urol. 2014 Sep 22.
pii: S0302-2838(14)00891-4. doi: 10.1016/j.eururo.2014.08.079. [Epub ahead
of print]
Abstract
| Related
citations
|
|
DIAGNOSIS AND EVALUATION
|
|
|
Glazer
DI, Davenport MS, Khalatbari S, Cohan RH, Ellis JH, Caoili EM, Stein EB,
Childress JC, Masch WR, Brown JM, Mollard BJ, Montgomery JS, Palapattu GS,
Francis IR.
Mass-like
peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4 + 3
and higher) prostate cancer.
Abdom Imaging. 2014
Sep 6. [Epub ahead of print]
Abstract
| Related
citations
|
|
Hong
SK, Vertosick E, Sjoberg DD, Scardino PT, Eastham JA.
Insignificant
disease among men with intermediate-risk prostate cancer.
World J Urol.
2014 Sep 27. [Epub ahead of print]
Abstract
| Related
citations
|
|
Zhang
Q, Sun LJ, Qi J, Yang ZG, Huang T, Huo RC.
Periprostatic
adiposity measured on magnetic resonance imaging correlates with prostate
cancer aggressiveness.
Urol J. 2014 Sep
6;11(4):1793-9.
Abstract
| Full
text | Related
citations
|
|
ETIOLOGY AND PATHOGENESIS
|
|
|
Klap
J, Schmid M, Loughlin KR.
The
relationship between total testosterone levels and prostate cancer: A
review of the continuing controversy.
J Urol. 2014 Sep
23. pii: S0022-5347(14)04490-5. doi: 10.1016/j.juro.2014.07.123. [Epub
ahead of print]
Abstract
| Related
citations
|
|
Park
SW, Kim JY, Kim YS, Lee SJ, Lee SD, Chung MK.
A
milk protein, casein, as a proliferation promoting factor in prostate
cancer cells.
World J Mens
Health. 2014 Aug;32(2):76-82. doi: 10.5534/wjmh.2014.32.2.76. Epub
2014 Aug 26.
Abstract
| Full
text | Related
citations
|
|
INTEGRATIVE MEDICINE
|
|
|
Fair
WR, Fleshner NE, Heston W.
Cancer
of the prostate: a nutritional disease?
Urology. 1997 Dec;50(6):840-8.
Abstract |
1Full
text | Related
citations
|
|
Ahmad
A, Biersack B, Li Y, Bao B, Kong D, Ali S, Banerjee S, Sarkar FH.
Perspectives
on the role of isoflavones in prostate cancer.
AAPS J. 2013 Oct;15(4):991-1000.
doi: 10.1208/s12248-013-9507-1. Epub 2013 Jul 4.
Abstract
| Full
text | Related
citations
|
|
Leitzmann
MF, Stampfer MJ, Michaud DS, Augustsson K, Colditz GC, Willett WC,
Giovannucci EL.
Dietary
intake of n-3 and n-6 fatty acids and the risk of prostate cancer.
Am J
Clin Nutr. 2004 Jul;80(1):204-16.
Abstract
| Full
text | Related
citations
|
|
Posadzki
P, Lee MS, Onakpoya I, Lee HW, Ko BS, Ernst E.
Dietary
supplements and prostate cancer: a systematic review of double-blind,
placebo-controlled randomised clinical trials.
Maturitas. 2013 Jun;75(2):125-30.
doi: 10.1016/j.maturitas.2013.03.006. Epub 2013 Apr 6.
Abstract
| Full
text | Related
citations
|
|
OVERALL MANAGEMENT
|
|
| Moran
BJ, DeRose P, Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ,
Mohler JL, Rosenthal SA, Rossi CJ Jr, Yamada Y, Merrick GS.
ACR
Appropriateness CriteriaŽ definitive external beam irradiation in stage
T1 and T2 prostate cancer.
Am J Clin
Oncol. 2011 Dec;34(6):636-47. doi: 10.1097/COC.0b013e3182354a65.
Abstract
| Full
text | Related
citations
|
|
Nguyen
PL, Aizer A, Assimos DG, D'Amico AV, Frank SJ, Gottschalk AR, Gustafson
GS, Hsu IC, McLaughlin PW, Merrick G, Rosenthal SA, Showalter TN, Taira
AV, Vapiwala N, Yamada Y, Davis BJ; American College of Radiology, Expert
Panel on Radiation OncologyProstate.
ACR
Appropriateness CriteriaŽ Definitive External-Beam Irradiation in stage
T1 and T2 prostate cancer.
Am J Clin
Oncol. 2014 Jun;37(3):278-88. doi: 10.1097/COC.0000000000000049.
Abstract
| Full
text | Related
citations
|
|
PROGNOSIS AND OUTCOME
|
|
|
Boorjian
SA, Eastham JA, Graefen M, Guillonneau B, Karnes RJ, Moul JW, Schaeffer EM,
Stief C, Zorn KC.
A
critical analysis of the long-term impact of radical prostatectomy on
cancer control and function outcomes.
Eur Urol. 2012 Apr;61(4):664-75.
doi: 10.1016/j.eururo.2011.11.053. Epub 2011 Dec 7.
Abstract
| Full
text | Related
citations
|
| Daskivich
TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM,
Stanford JL, Stroup AM, Litwin MS, Penson DF.
Prediction
of Long-term Other-cause Mortality in Men With Early-stage Prostate
Cancer: Results From the Prostate Cancer Outcomes Study.
Urology. 2014 Sep 23. pii:
S0090-4295(14)00703-1. doi: 10.1016/j.urology.2014.07.003. [Epub ahead of
print]
Abstract
| Related
citations
|
|
Hatzichristou
D.
Post-radical
prostatectomy erectile function: the five Ws and the H.
Eur Urol. 2012 Aug;62(2):287-9.
doi: 10.1016/j.eururo.2012.05.039. Epub 2012 May 22.
Abstract
| Full
text | Related
citations
|
|
Hatzimouratidis
K, Burnett AL, Hatzichristou D, McCullough AR, Montorsi F, Mulhall JP.
Phosphodiesterase
type 5 inhibitors in postprostatectomy erectile dysfunction: a critical
analysis of the basic science rationale and clinical application.
Eur Urol. 2009 Feb;55(2):334-47.
doi: 10.1016/j.eururo.2008.10.028. Epub 2008 Oct 21
Abstract
| Full
text | Related
citations
|
| Lepor
H.
Radical
prostatectomy for long-term functional and oncologic outcomes.
Eur Urol. 2012 Apr;61(4):676-8.
doi: 10.1016/j.eururo.2012.01.004. Epub 2012 Jan 11.
Abstract
| Full
text | Related
citations
|
| Martin
NE, Massey L, Stowell C, Bangma C, Briganti A, Bill-Axelson A, Blute M,
Catto J, Chen RC, D'Amico AV, Feick G, Fitzpatrick JM, Frank SJ, Froehner
M, Frydenberg M, Glaser A, Graefen M, Hamstra D, Kibel A, Mendenhall N,
Moretti K, Ramon J, Roos I, Sandler H, Sullivan FJ, Swanson D, Tewari A,
Vickers A, Wiegel T, Huland H.
Defining
a Standard Set of Patient-centered Outcomes for Men with Localized
Prostate Cancer.
Eur Urol. 2014 Sep 15.
pii: S0302-2838(14)00845-8. doi: 10.1016/j.eururo.2014.08.075. [Epub ahead
of print]
Abstract
| Related
citations
|
|
Salonia
A, Burnett AL, Graefen M, Hatzimouratidis K, Montorsi F, Mulhall JP, Stief
C.
Prevention
and management of postprostatectomy sexual dysfunctions part 2: recovery
and preservation of erectile function, sexual desire, and orgasmic
function.
Eur Urol. 2012 Aug;62(2):273-86.
doi: 10.1016/j.eururo.2012.04.047. Epub 2012 May 3.
Abstract
| Full
text | Related
citations
|
| Sugihara
T, Yu C, Kattan MW, Yasunaga H, Ihara H, Onozawa M, Hinotsu S, Akaza H.
Long-term
Survival of Extremely Advanced Prostate Cancer Patients Diagnosed with
Prostate-specific Antigen over 500 ng/ml.
Jpn J
Clin Oncol. 2014 Sep 19. pii: hyu142. [Epub ahead of print]
Abstract
| Related
citations
|
|
PSYCHOSOCIAL ASPECTS
|
|
|
Punnen
S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR.
Long-term
Health-related Quality of Life After Primary Treatment for Localized
Prostate Cancer: Results from the CaPSURE Registry.
Eur Urol. 2014 Sep 18.
pii: S0302-2838(14)00844-6. doi: 10.1016/j.eururo.2014.08.074. [Epub ahead
of print]
Abstract
| Related
citations
|
|
STAGING
|
|
|
Kim
L, Min M, Roos D, Nguyen L, Yeoh E.
Are
staging investigations being overused in patients with low and
intermediate risk prostate cancer?
J
Med Imaging Radiat Oncol. 2014 Sep 4. doi: 10.1111/1754-9485.12234.
[Epub ahead of print]
Abstract
| Related
citations
|
|